Clorox reported a 12% increase in net sales to $2.0 billion, driven by favorable price mix. Diluted EPS increased by 75% to $1.42, and adjusted EPS increased by 80% to $1.67. The company delivered double-digit organic net sales growth in all reportable segments and achieved sequential quarterly improvement in gross margin.
Net sales increased 12% to $2.0 billion.
Organic sales were up 14%.
Diluted EPS increased 75% to $1.42.
Adjusted EPS increased 80% to $1.67.
Net sales are expected to be flat to up 2% compared to the prior year. Organic sales are expected to be up 2% to up 4%. Diluted EPS is expected to be between $4.65 and $4.95, or an increase between 290% and 316%, respectively, primarily due to the impact of the noncash impairment charge in the VMS business in fiscal year 2023. Adjusted EPS is expected to be between $5.60 and $5.90, or an increase between 10% and 16%, respectively.
Visualization of income flow from segment revenue to net income